Blair Jackson
Director of Finance/CFO at ALKERMES PLC
Net worth: 4 M $ as of 2024-03-30
Profile
Blair C. Jackson is on the board of Alkermes Pharma Ireland Ltd. and Chief Operating Officer & Executive Vice President of Alkermes Plc. In his past career Mr. Jackson was Vice President-Business Development for Alkermes, Inc. Mr. Jackson received an undergraduate degree from the University of Calgary, an MBA and an undergraduate degree from the University of Alberta and a graduate degree from Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-25 | 157,802 ( 0.09% ) | 4 M $ | 2024-03-30 |
Blair Jackson active positions
| Companies | Position | Start |
|---|---|---|
| ALKERMES PLC | Director of Finance/CFO | 2024-01-31 |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The private company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Director/Board Member | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Director/Board Member | 2018-09-30 |
Former positions of Blair Jackson
| Companies | Position | End |
|---|---|---|
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Director/Board Member | 2014-12-31 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Training of Blair Jackson
| Massachusetts Institute of Technology | Graduate Degree |
| University of Alberta | Masters Business Admin |
| University of Calgary | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Private companies | 4 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The private company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Health Technology |
- Stock Market
- Insiders
- Blair Jackson
